Variables (subgroup) | Characteristics | Included studies | Pooled prevalence (95% CI) | I2 | P-value |
---|---|---|---|---|---|
By design | Cross- sectional | 25 | 18.81(16.10–21.50) | 95% | < 0.001 |
Case- control | 2 | 18.81(16.10–21.51) | 0.0% | 0.717 | |
Cohort | 3 | 20.41(18.42–22.39) | 78.4% | 0.010 | |
By study setting | Health facility | 23 | 17.72(17.06–18.38) | 93.8% | < 0.001 |
Community | 7 | 26.77(25.61–27.93) | 87.3% | 0.001 | |
By country | South Africa | 9 | 23.54 (22.48, 24.60) | 89.9% | < 0.001 |
Ethiopia | 8 | 16.79 (15.62, 17.97) | 96.% | < 0.001 | |
Nigeria | 4 | 15.73(13.99–17.47) | 97.4% | < 0.001 | |
Uganda | 2 | 20.18(11.31–15.59) | 92.9% | < 0.001 | |
Tanzania | 2 | 13.45(11.31–15.59) | 14.9% | 0.278 | |
Zambia | 1 | 21.20 (15.36, 27.04) | . | . | |
Burkina Faso | 1 | 18.50 (15.16, 21.84) | . | . | |
DR Congo | 1 | 32.50 (26.57, 38.43 | . | . | |
Congo | 1 | 23.30 (21.81, 24.79) | . | . | |
Ghana | 1 | 20.40 (16.44, 24.36) | . | . |